The spring has brought a wave of exciting news for Next-Generation Sequencing (NGS) tests in oncology and for liquid biopsy technologies. Liquid biopsy, typically non-invasive …

The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone with the …

Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overall survival …